Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
03/12/2014 | EP2704570A1 Drug substances, pharmeceutical compositions and methods for preparing the same |
03/12/2014 | EP2704569A1 Carbonyl containing compounds for controlling and repelling cimicidae populations |
03/12/2014 | EP2704568A1 Diazeniumdiolate cyclohexyl derivatives |
03/12/2014 | CN1798566B Method for preparing extract of caralluma nebrownii plant and use thereof |
03/12/2014 | CN103635586A Crystalline cefoperazone intermediate, preparing method and application thereof |
03/12/2014 | CN103635559A Special fluid composition and use thereof |
03/12/2014 | CN103635491A Shark-like chondroitin sulphate and process for the preparation thereof |
03/12/2014 | CN103635478A Novel cephem compound having catechol or pseudo-catechol structure |
03/12/2014 | CN103635477A Novel esters of N-acylated derivatives of amino acids and isosorbide, method for preparing same, and use thereof in cosmetics and as drug |
03/12/2014 | CN103635473A Dispiropyrrolidine derivative |
03/12/2014 | CN103635472A Serine/threonine kinase inhibitors |
03/12/2014 | CN103635467A Oxazepines as ion channel modulators |
03/12/2014 | CN103635466A Aromatic amides and uses thereof |
03/12/2014 | CN103635465A Process for the preparation of a chiral compound |
03/12/2014 | CN103635460A Compounds for the treatment of addiction |
03/12/2014 | CN103635458A Trpv1 antagonists |
03/12/2014 | CN103635452A Reduced coenzyme Q10 crystal having excellent stability |
03/12/2014 | CN103635446A Pentylenetetrazole derivatives |
03/12/2014 | CN103635205A Photodynamic therapy using photosensitizing agent or 5-aminolevulinic acid |
03/12/2014 | CN103635198A Metabolized conditioned growth medium and methods of use |
03/12/2014 | CN103635197A Method of treating keloids or hypertrophic scars using antisense compounds targeting connective tissue growth factor (CTGF) |
03/12/2014 | CN103635196A Compositions, methods of treatment and diagnostics for treatment of hepatic steatosis alone or in combination with a hepatitis c virus infection |
03/12/2014 | CN103635195A Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage |
03/12/2014 | CN103635194A Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation |
03/12/2014 | CN103635193A Small molecule RNase inhibitors and methods of use |
03/12/2014 | CN103635192A Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use |
03/12/2014 | CN103635191A Small molecule RNASE inhibitors and methods of use |
03/12/2014 | CN103635190A Treatment regimens |
03/12/2014 | CN103635189A Combination therapy comprising CDK4/6 inhibitor and PI3K inhibitor for use in treatment of cancer |
03/12/2014 | CN103635188A Methods and compositions using PDE4 inhibitors for the treatment and management of autoimmune and inflammatory diseases |
03/12/2014 | CN103635187A Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits |
03/12/2014 | CN103635186A Inhibitors of phosphatidic acid phosphohydrolase (PAP), including D-propranolol and analogs thereof, alone or in combination with desipramine, for the treatment of cancers that depend on the epidermal growth factor receptor (EGFR), oncogenic variants thereof and other members of the ERBB/HER family |
03/12/2014 | CN103635185A Eye fatigue suppression composition and food and drink containing same |
03/12/2014 | CN103635184A Soyasapogenol composition |
03/12/2014 | CN103635183A Method of treating lymphoma using pyridopyrimidinone inhibitors of PI3K/MTOR |
03/12/2014 | CN103635181A Method for microencapsulating phosphatidylserine |
03/12/2014 | CN103635088A Migrastatins and uses thereof |
03/12/2014 | CN103626880A Prunella vulgaris polysaccharide, and preparation method and purpose thereof |
03/12/2014 | CN103626826A Azo bond contained glycogen phosphorylase inhibitor cholic acid derivative and preparation method and medical application thereof |
03/12/2014 | CN103626825A Liver-targeted glycogen phosphorylase inhibitor cholic acid derivative and preparation method and medical application thereof |
03/12/2014 | CN103626824A Hemsleya amabilis cucurbitane tetracyclic triterpene compound, pharmaceutical composition comprising compound and application of pharmaceutical composition and compound |
03/12/2014 | CN103626813A Heterobifunctional pan-selectin inhibitors |
03/12/2014 | CN103626812A Novel parishin compound in gastrodia elata and application of compound |
03/12/2014 | CN103626803A Solid of tenofovir disoproxil, and preparation method and application thereof |
03/12/2014 | CN103626801A Fostrecin (FST) derivative and medical application and preparation method thereof |
03/12/2014 | CN103626800A Fostrecin (FST) derivative and medical application and preparation method thereof |
03/12/2014 | CN103626787A Thienothio compound and application thereof |
03/12/2014 | CN103626785A Anticoagulant fructus psoraleae active ingredient and extraction and separation method and application thereof |
03/12/2014 | CN103626783A Dicyclic fused heterocyclic compounds, and applications and pharmaceutical compositions thereof |
03/12/2014 | CN103626781A Targeted anti-cancer molecule gefitinib phthalocyanine conjugate, and preparation and application thereof |
03/12/2014 | CN103626777A PLK inhibitor salts |
03/12/2014 | CN103626776A Pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives, preparation methods of pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives, and application of pyrazolo[1,5-alpha] pyrimidine nitrogen mustard derivatives in oncotherapy |
03/12/2014 | CN103626775A DPP-4 inhibitor with diazine structure |
03/12/2014 | CN103626773A Salt of vasicine derivative |
03/12/2014 | CN103626769A Substituted sulfydryl hexahydric heteroaromatic imidazole derivative and preparation method and application thereof |
03/12/2014 | CN103626765A Substituted azaindole compound and salt, composition and application thereof |
03/12/2014 | CN103626764A Salt of harmol derivative |
03/12/2014 | CN103626762A Benazepine compound and application thereof |
03/12/2014 | CN103626761A Benazepine compound and application thereof as antitumor drug |
03/12/2014 | CN103626760A Salt of harmine derivative derivative |
03/12/2014 | CN103626752A Dihydropyrimidine compounds and application of same in drugs |
03/12/2014 | CN103626749A Substituted oxazolidinone compound, and pharmaceutical composition containing compound and application thereof |
03/12/2014 | CN103626747A N-(2, 3-dihydrobenzofuran-5-yl) benzopyran-4-amide and preparation method and application thereof |
03/12/2014 | CN103626744A Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid |
03/12/2014 | CN103626742A Bi-aryl meta-pyrimidine inhibitors of kinases |
03/12/2014 | CN103626741A Heterocyclic aminopyrimidine compound with adenosine receptor antagonist activity |
03/12/2014 | CN103626739A Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals |
03/12/2014 | CN103626738A Pomalidomide crystal and preparation method thereof |
03/12/2014 | CN103626732A Coagulation-promoting fructus psoraleae effective component, and extraction separation method and application thereof |
03/12/2014 | CN103626722A Hypoglycemic compound of nitric oxide donor type, preparation method and purpose thereof |
03/12/2014 | CN103626720A Mitotic kinesin inhibitors and methods of use thereof |
03/12/2014 | CN103626713A Aza (oxa)-cyclopentane-2- ketone (thione) compounds, medicine compositions thereof, preparation method and applications |
03/12/2014 | CN103626709A Ligustrazine phosphate compound and drug composition containing ligustrazine phosphate compound and ginkgo leaf effective ingredients |
03/12/2014 | CN103626705A 1-(3-benzoylaminobenzyl)-1H-indazole-3-carboxamide compounds, and preparation method and antiviral use thereof |
03/12/2014 | CN103626700A Salt of cyclopropane dicarboxamide derivative |
03/12/2014 | CN103626694A Unsaturated cyclic amine derivatives, preparation method and medical uses thereof |
03/12/2014 | CN103626693A A class of pleuromytilin derivatives, drug composition, synthesis methods and uses thereof |
03/12/2014 | CN103626692A 3,5-diaryl-ylidene piperidone derivatives and application thereof in preparing blood glucose-reducing and fat-reducing medicine |
03/12/2014 | CN103626680A Diethylstilbestrol disulfamate derivatives and medicinal uses thereof |
03/12/2014 | CN103626653A Rabdosia rubescens procoagulant effective components, and preparation method and application thereof |
03/12/2014 | CN103626636A Novel streptomycete sesquiterpene triol A and preparation method and application |
03/12/2014 | CN103623458A Pseudo-ginsheng blood circulation and healing promoting water-soluble hemostatic gauze |
03/12/2014 | CN103623456A Biological membrane device used for wound surface and preparation method of biological membrane device |
03/12/2014 | CN103623425A Medicament for inhibiting neovascularization diseases angiogenesis by using dual-target antagomir |
03/12/2014 | CN103623423A Agomelatine inclusion compound and preparation method and application thereof |
03/12/2014 | CN103623421A Method for preparing protamine-deoxycholic acid conjugate with heparin transfer function |
03/12/2014 | CN103623419A Chlorotoxin-targeted oxidized graphene nanometer material used for transporting antitumor drug |
03/12/2014 | CN103623412A Stable cefaclor tablet composition and preparation method thereof |
03/12/2014 | CN103623409A Antcin derivatives in combination with anti-cancer drugs in the treatment and/or prevention of tumors |
03/12/2014 | CN103623394A Application of PEG-HM-3 and platinum, taxol or Emtriva medicines to preparation of solid tumor medicines |
03/12/2014 | CN103623392A Antitumour combinations containing a vegf inhibiting agent and irinotecan |
03/12/2014 | CN103623390A Glutamine for use in treating injury |
03/12/2014 | CN103623373A Orally-taken traditional Chinese medicine |
03/12/2014 | CN103623365A Externally-applied medicine for rapid cardiac first aid and preparation method thereof |
03/12/2014 | CN103623314A Comprehensive external application drug for treating osseous rheumatism |
03/12/2014 | CN103623293A Micro-ecological oral preparation |
03/12/2014 | CN103623285A Medicinal composition for treating condyloma acuminata |
03/12/2014 | CN103623275A Formula of health-care and eye-protecting nutrient solution |
03/12/2014 | CN103623257A Medicine for treating tumors |
03/12/2014 | CN103623256A Medicine for treating tumors |